BDBM536291 (5S)-2-((4R)-1-(2-(3-((6-(2-((4-((3-Ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethoxy)hexa-2,4-diyn-1-yl)oxy)isoxazol-5-yl)-3-methylbutanoyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one ::US11242344, Example 1004.1

SMILES C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOCC#CC#CCOc4cc([C@H](C(=O)N5C[C@H](O)C[C@H]5C5=NC(=O)[C@](C)(c6ccc(-c7scnc7C)cc6)N5)C(C)C)on4)cc23)c1

InChI Key InChIKey=GDUPOTCODJXPBK-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 536291   

LigandChemical structure of BindingDB Monomer ID 536291BDBM536291((5S)-2-((4R)-1-(2-(3-((6-(2-((4-((3-Ethynylphenyl)...)
Affinity DataIC50: 6.25E+3nMAssay Description:The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 536291BDBM536291((5S)-2-((4R)-1-(2-(3-((6-(2-((4-((3-Ethynylphenyl)...)
Affinity DataIC50: 6.83E+4nMAssay Description:The VHL NanoBRET Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL NanoB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent